1. Home
  2. WST vs PHM Comparison

WST vs PHM Comparison

Compare WST & PHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • PHM
  • Stock Information
  • Founded
  • WST 1923
  • PHM 1950
  • Country
  • WST United States
  • PHM United States
  • Employees
  • WST N/A
  • PHM N/A
  • Industry
  • WST Medical/Dental Instruments
  • PHM Homebuilding
  • Sector
  • WST Health Care
  • PHM Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • PHM Nasdaq
  • Market Cap
  • WST 18.9B
  • PHM 25.7B
  • IPO Year
  • WST N/A
  • PHM N/A
  • Fundamental
  • Price
  • WST $253.59
  • PHM $137.14
  • Analyst Decision
  • WST Buy
  • PHM Buy
  • Analyst Count
  • WST 7
  • PHM 14
  • Target Price
  • WST $332.50
  • PHM $136.71
  • AVG Volume (30 Days)
  • WST 561.0K
  • PHM 1.9M
  • Earning Date
  • WST 10-23-2025
  • PHM 10-21-2025
  • Dividend Yield
  • WST 0.35%
  • PHM 0.64%
  • EPS Growth
  • WST N/A
  • PHM 2.26
  • EPS
  • WST 6.68
  • PHM 13.40
  • Revenue
  • WST $2,960,200,000.00
  • PHM $17,694,541,000.00
  • Revenue This Year
  • WST $6.28
  • PHM N/A
  • Revenue Next Year
  • WST $6.02
  • PHM $0.08
  • P/E Ratio
  • WST $37.97
  • PHM $10.24
  • Revenue Growth
  • WST 2.90
  • PHM 5.04
  • 52 Week Low
  • WST $187.43
  • PHM $88.07
  • 52 Week High
  • WST $352.33
  • PHM $149.47
  • Technical
  • Relative Strength Index (RSI)
  • WST 56.31
  • PHM 62.16
  • Support Level
  • WST $249.94
  • PHM $134.21
  • Resistance Level
  • WST $264.06
  • PHM $139.69
  • Average True Range (ATR)
  • WST 5.67
  • PHM 3.11
  • MACD
  • WST 0.67
  • PHM -0.17
  • Stochastic Oscillator
  • WST 53.28
  • PHM 61.11

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About PHM PulteGroup Inc.

PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.

Share on Social Networks: